CD47 Targeting Therapeutics Market Outlook: Trends, Innovations, and Future Growth
The CD47 Targeting Therapeutics Market is on a trajectory of remarkable growth, with projections indicating a surge from USD 2.41 billion in 2024 to an estimated USD 23.3 billion by 2035. This expansive increase reflects a compound annual growth rate (CAGR) of 22.89%, underscoring the burgeoning interest in immunotherapeutic approaches to treat cancer. The rising prevalence of cancer cases...
0 Reacties 0 aandelen 13 Views 0 voorbeeld